Literature DB >> 7513703

Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1.

S Sugimoto1, T J Wandless, S E Shoelson, B G Neel, C T Walsh.   

Abstract

The cytoplasmic insulin receptor substrate-1 (IRS-1), which is multiply phosphorylated in vivo on tyrosine residues, is a known binding protein for the tandem src homology 2 (SH2) domain-containing protein tyrosine phosphatase, SH-PTP2. Eleven phosphotyrosyl (pY) peptides from IRS-1 were screened for allosteric activation of SH-PTP2 phosphatase activity toward phosphorylated, reduced, carboxyamidomethylated, and maleylated-lysozyme. Peptides IRS-1pY895, IRS-1pY1172, and IRS-1pY1222 showed up to 50-fold acceleration of dephosphorylation. Analyses of Arg to Lys mutants in either or both SH2 domains indicate that both the N-terminal (N-SH2) and C-terminal (C-SH2) domains function in allosteric activation. Direct determination by surface plasmon resonance of the dissociation constants between pY peptides and glutathione S-transferase fusions to N-SH2 and C-SH2 domains reveals a 240-fold preference of the N-SH2 domain (compared with the C-SH2 domain) for IRS-1pY1172. The N-SH2 domain prefers IRS-1pY1172 > IRS-1pY895 > IRS-1pY1222, whereas C-SH2 domain prefers IRS-1pY1222 > IRS-1pY895 > IRS-1pY1172. These data suggest that each SH2 domain can bind to a distinct pY sequence of multiply phosphorylated protein substrates such as IRS-1, while activating hydrolysis at a third pY sequence bound in the SH-PTP2 active site. In addition, proteolysis and truncation studies reveal an autoregulatory function for the C-terminal region of SH-PTP2. Limited tryptic cleavage within the C-terminus results in 27-fold activation of protein tyrosine phosphatase activity. The activated tryptic fragment cannot be further activated by pY peptide binding to the SH2 domains indicating that autoregulatory functions of the SH2 domains are dependent on the C-terminal region. These data suggest that multiple levels for control of SH-PTP2 enzymatic activity may exist in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513703

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering.

Authors:  A Kodama; T Matozaki; A Fukuhara; M Kikyo; M Ichihashi; Y Takai
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

2.  Kinase activation through dimerization by human SH2-B.

Authors:  Masahiro Nishi; Eric D Werner; Byung-Chul Oh; J Daniel Frantz; Sirano Dhe-Paganon; Lone Hansen; Jongsoon Lee; Steven E Shoelson
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Structure-based kinetic models of modular signaling protein function: focus on Shp2.

Authors:  Dipak Barua; James R Faeder; Jason M Haugh
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

4.  Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides.

Authors:  T Kimura; H Sakamoto; E Appella; R P Siraganian
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.

Authors:  S Tanaka; J R Wands
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain.

Authors:  B Xu; W T Miller
Journal:  Mol Cell Biochem       Date:  1996-05-10       Impact factor: 3.396

7.  Structural mechanism associated with domain opening in gain-of-function mutations in SHP2 phosphatase.

Authors:  Eva Darian; Olgun Guvench; Bing Yu; Cheng-Kui Qu; Alexander D MacKerell
Journal:  Proteins       Date:  2011-03-01

8.  Structural determinants of SHP-2 function and specificity in Xenopus mesoderm induction.

Authors:  A M O'Reilly; B G Neel
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

9.  The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase.

Authors:  S Pons; T Asano; E Glasheen; M Miralpeix; Y Zhang; T L Fisher; M G Myers; X J Sun; M F White
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations.

Authors:  Zhi-Hong Yu; Jie Xu; Chad D Walls; Lan Chen; Sheng Zhang; Ruoyu Zhang; Li Wu; Lina Wang; Sijiu Liu; Zhong-Yin Zhang
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.